Endicott JA - Search Results

1

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure-Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines.

Coxon CR, Anscombe E, Harnor SJ, Martin MP, Carbain B, Golding BT, Hardcastle IR, Harlow LK, Korolchuk S, Matheson CJ, Newell DR, Noble ME, Sivaprakasam M, Tudhope SJ, Turner DM, Wang LZ, Wedge SR, Wong C, Griffin RJ, Endicott JA, Cano C. Coxon CR, et al. Among authors: endicott ja. J Med Chem. 2017 Mar 9;60(5):1746-1767. doi: 10.1021/acs.jmedchem.6b01254. Epub 2017 Feb 14. J Med Chem. 2017. PMID: 28005359 Free PMC article.

2

The crystal structure of p13suc1, a p34cdc2-interacting cell cycle control protein.

Endicott JA, Noble ME, Garman EF, Brown N, Rasmussen B, Nurse P, Johnson LN. Endicott JA, et al. EMBO J. 1995 Mar 1;14(5):1004-14. doi: 10.1002/j.1460-2075.1995.tb07081.x. EMBO J. 1995. PMID: 7889931 Free PMC article.

3

The crystal structure of cyclin A.

Brown NR, Noble ME, Endicott JA, Garman EF, Wakatsuki S, Mitchell E, Rasmussen B, Hunt T, Johnson LN. Brown NR, et al. Among authors: endicott ja. Structure. 1995 Nov 15;3(11):1235-47. doi: 10.1016/s0969-2126(01)00259-3. Structure. 1995. PMID: 8591034 Free article.

4

Protein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2.

Lawrie AM, Noble ME, Tunnah P, Brown NR, Johnson LN, Endicott JA. Lawrie AM, et al. Among authors: endicott ja. Nat Struct Biol. 1997 Oct;4(10):796-801. doi: 10.1038/nsb1097-796. Nat Struct Biol. 1997. PMID: 9334743

5

The cyclin box fold: protein recognition in cell-cycle and transcription control.

Noble ME, Endicott JA, Brown NR, Johnson LN. Noble ME, et al. Among authors: endicott ja. Trends Biochem Sci. 1997 Dec;22(12):482-7. doi: 10.1016/s0968-0004(97)01144-4. Trends Biochem Sci. 1997. PMID: 9433129 Review.

6

Structural principles in cell-cycle control: beyond the CDKs.

Endicott JA, Noble ME. Endicott JA, et al. Structure. 1998 May 15;6(5):535-41. doi: 10.1016/s0969-2126(98)00055-0. Structure. 1998. PMID: 9634691 Free article. Review.

7

Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity.

Brown NR, Noble ME, Lawrie AM, Morris MC, Tunnah P, Divita G, Johnson LN, Endicott JA. Brown NR, et al. Among authors: endicott ja. J Biol Chem. 1999 Mar 26;274(13):8746-56. doi: 10.1074/jbc.274.13.8746. J Biol Chem. 1999. PMID: 10085115 Free article.

8

Chemical inhibitors of cyclin-dependent kinases: insights into design from X-ray crystallographic studies.

Noble ME, Endicott JA. Noble ME, et al. Among authors: endicott ja. Pharmacol Ther. 1999 May-Jun;82(2-3):269-78. doi: 10.1016/s0163-7258(98)00051-5. Pharmacol Ther. 1999. PMID: 10454204 Review.

9

The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases.

Brown NR, Noble ME, Endicott JA, Johnson LN. Brown NR, et al. Among authors: endicott ja. Nat Cell Biol. 1999 Nov;1(7):438-43. doi: 10.1038/15674. Nat Cell Biol. 1999. PMID: 10559988

10

Cyclin-dependent kinases: inhibition and substrate recognition.

Endicott JA, Noble ME, Tucker JA. Endicott JA, et al. Curr Opin Struct Biol. 1999 Dec;9(6):738-44. doi: 10.1016/s0959-440x(99)00038-x. Curr Opin Struct Biol. 1999. PMID: 10607671 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters